Otoband efficacy on Tinnitus for Tinnitus

Phase-Based Progress Estimates
Otoband - Device
All Sexes
What conditions do you have?

Study Summary

This trial will test whether the OtoBand, a wearable device, can reduce the perceived loudness of tinnitus for people with the condition. The study will be placebo-controlled, meaning that some participants will use the OtoBand while others will use a similar-looking device that does not produce any sound. The researchers conducting the study will not know which participants are using the OtoBand and which are using the placebo, in order to avoid bias.

Treatment Effectiveness

Effectiveness Progress

1 of 3

Other trials for Tinnitus

Study Objectives

1 Primary · 2 Secondary · Reporting Duration: Device use log over two week period of use by the study participant

Device use log over two week period of use by the study participant
Identification of a preferred power level for tinnitus as determined by Otoband device log.
Forms filled out daily over two week period by the study participant
Change in Quality of Life Measures as measured by the Tinnitus Handicap Questionnaire
Change in bothersomeness of Tinnitus as measured by Tinnitus Handicap Questionnaire

Trial Safety

Safety Progress

1 of 3

Other trials for Tinnitus

Trial Design

2 Treatment Groups

Otoband efficacy on Tinnitus
1 of 2
Placebo device efficacy on Tinnitus
1 of 2
Active Control
Non-Treatment Group

40 Total Participants · 2 Treatment Groups

Primary Treatment: Otoband efficacy on Tinnitus · Has Placebo Group · N/A

Placebo device efficacy on Tinnitus
PlaceboComparator Group · 1 Intervention: Placebo · Intervention Types: Device
Otoband efficacy on Tinnitus
ActiveComparator Group · 1 Intervention: Otoband · Intervention Types: Device

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: device use log over two week period of use by the study participant

Who is running the clinical trial?

Otolith LabsLead Sponsor
7 Previous Clinical Trials
189 Total Patients Enrolled
Didier Depireux, PhDPrincipal InvestigatorOtolith Labs
3 Previous Clinical Trials
81 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 6 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: October 5th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.

Who else is applying?

What state do they live in?
North Carolina16.7%
How old are they?
18 - 6571.4%
What site did they apply to?
OtolithLabs https://otolithlabs.com/tinnitustelehealthstudy/100.0%
What portion of applicants met pre-screening criteria?
Met criteria92.3%
Did not meet criteria7.7%
Why did patients apply to this trial?
  • "I have a hard case of tinnitus. It feels like I'm walking around with ear muffs on my head."
  • "My life is held hostage by the noise in my head. Exposure to the high frequency noises of the city makes it worse so I am virtually a prisoner of my home."
What questions have other patients asked about this trial?
  • "Is this Washington state or DC?"
  • "How long do the screening visits take?"
How many prior treatments have patients received?